TRXBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
TRex Bio, Inc.
$14.80+0.79 (+5.64%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
TRex Bio has not reported a dividend
No dividend per share appears in TRex Bio's annual filings since fiscal –.